These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. CPEO and KSS differ in the percentage and location of the mtDNA deletion. López-Gallardo E; López-Pérez MJ; Montoya J; Ruiz-Pesini E Mitochondrion; 2009 Sep; 9(5):314-7. PubMed ID: 19410662 [TBL] [Abstract][Full Text] [Related]
10. Deletion screening of mitochondrial DNA via multiprimer DNA amplification. Ernst BP; Wilichowski E; Wagner M; Hanefeld F Mol Cell Probes; 1994 Feb; 8(1):45-9. PubMed ID: 8028607 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. Moraes CT; DiMauro S; Zeviani M; Lombes A; Shanske S; Miranda AF; Nakase H; Bonilla E; Werneck LC; Servidei S N Engl J Med; 1989 May; 320(20):1293-9. PubMed ID: 2541333 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of mitochondrial DNA analysis in chronic progressive external ophthalmoplegia (CPEO)]. Kornblum C; Kunz WS; Klockgether T; Roggenkämper P; Schröder R Klin Monbl Augenheilkd; 2004 Dec; 221(12):1057-61. PubMed ID: 15599814 [TBL] [Abstract][Full Text] [Related]
13. Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression? Auré K; Ogier de Baulny H; Laforêt P; Jardel C; Eymard B; Lombès A Brain; 2007 Jun; 130(Pt 6):1516-24. PubMed ID: 17439982 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. Remes AM; Majamaa-Voltti K; Kärppä M; Moilanen JS; Uimonen S; Helander H; Rusanen H; Salmela PI; Sorri M; Hassinen IE; Majamaa K Neurology; 2005 Mar; 64(6):976-81. PubMed ID: 15781811 [TBL] [Abstract][Full Text] [Related]
15. [Partial deletion of mitochondrial DNA in mitochondrial encephalomyopathies]. Wang W; Zhang J; Guo Y; Guo Z; Ren H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):278-83. PubMed ID: 10453567 [TBL] [Abstract][Full Text] [Related]
16. [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy]. Wabbels B; Ali N; Kunz WS; Roggenkämper P; Kornblum C Ophthalmologe; 2008 Jun; 105(6):550-6. PubMed ID: 18373100 [TBL] [Abstract][Full Text] [Related]
17. [Disorders of mitochondrial energy metabolism in patients with the Kearns-Sayre syndrome]. Capková M; Tesarová M; Wenchich L; Cerná L; Hansíková H; Hůlková H; Hrubá E; Elleder M; Zeman J Cas Lek Cesk; 2002 Feb; 141(2):51-4. PubMed ID: 11925663 [TBL] [Abstract][Full Text] [Related]
18. Ophthalmoplegia in Mitochondrial Disease. Lee SJ; Na JH; Han J; Lee YM Yonsei Med J; 2018 Dec; 59(10):1190-1196. PubMed ID: 30450853 [TBL] [Abstract][Full Text] [Related]
19. A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples. De Coo IF; Gussinklo T; Arts PJ; Van Oost BA; Smeets HJ J Neurol Sci; 1997 Jul; 149(1):37-40. PubMed ID: 9168163 [TBL] [Abstract][Full Text] [Related]
20. [Chronic progressive external ophthalmoplegia (CPEO); mitochondrial DNA deletion, brain MRI and electrophysiological studies]. Nakagawa M; Tokimura M; Kuriyama M; Higuchi I; Osame M Rinsho Shinkeigaku; 1991 Sep; 31(9):981-6. PubMed ID: 1769162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]